Development of Molecular Targeted Anticancer Agents: Successes, Failures and Future Directions

E-ISSN： 1873-4286|11|2|265-272

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.11, Iss.2, 2005-01, pp. : 265-272

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Molecular targeted therapy in recurrent glioblastoma: current challenges and future directions

By Patel Mital Vogelbaum Michael A Barnett Gene H Jalali Rakesh Ahluwalia Manmeet S

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 9, 2012-09 ,pp. : 1247-1266

Informa Healthcare

Access to resources Recommend Favorite

Lipophilic Statins as Anticancer Agents: Molecular Targeted Actions and Proposal in Advanced Gynaecological Malignancies

Current Drug Targets, Vol. 16, Iss. 10, 2015-09 ,pp. : 1142-1159

Bentham Science Publishers

Access to resources Recommend Favorite

Anticancer Antifolates: Current Status and Future Directions

Current Pharmaceutical Design, Vol. 9, Iss. 31, 2003-12 ,pp. : 2593-2613

Bentham Science Publishers

Access to resources Recommend Favorite

Macrolides as Immunomodulatory Agents: Review and Future Directions

Medicinal Chemistry Reviews - Online, Vol. 1, Iss. 2, 2004-01 ,pp. : 151-161

Bentham Science Publishers

Access to resources Recommend Favorite

The successes and failures of HIV drug discovery

By Hashimoto Chie Tanaka Tomohiro Narumi Tetsuo Nomura Wataru Tamamura Hirokazu

Expert Opinion on Drug Discovery, Vol. 6, Iss. 10, 2011-10 ,pp. : 1067-1090

Informa Healthcare

Access to resources Recommend Favorite